Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis. American journal of obstetrics and gynecology [Am J Obstet Gynecol] Journal article

Title	Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis.
Author(s)	Stanford EJ, Chen A, Wan GJ, Lunacsek OE, Sand PK
Institution	Center for Advanced Pelvic Surgery, Belleville, IL 62801, USA. EJS222@aol.com
Source	Am J Obstet Gynecol 2008 Jul; 199(1):71.e1-10.
MeSH	Adult Amitriptyline Analgesics, Non-Narcotic Cystitis, Interstitial Cystoscopy Delivery of Health Care Female Histamine H1 Antagonists Humans Hydroxyzine Irrigation Middle Aged Narcotics Office Visits Pentosan Sulfuric Polyester Retrospective Studies
Abstract	OBJECTIVE: The aim of this study was to examine treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis (IC). STUDY DESIGN: Patients with a diagnosis of IC were identified from a national managed care administration claims database and classified into treatment cohorts. All-cause health care resource utilization and costs were calculated by treatment cohort. RESULTS: Patients treated with narcotics plus nonnarcotic analgesics were associated with higher mean health care costs. Patient cohorts treated with some of the more common oral therapies for interstitial cystitis, including pentosan polysulfate sodium, amitriptyline, and hydroxyzine, were associated with lower costs. Physician visits were fewest among patients treated with pentosan polysulfate sodium plus amitriptyline and hydroxyzine. Physician visits were higher for cohorts that included dimethyl sulfoxide plus cystoscopy or bladder irrigation, or narcotics plus nonnarcotic analgesics. CONCLUSION: Interstitial cystitis is associated with substantial costs and health care resource utilization.
Language	eng
Pub Type(s)	Journal Article Research Support, Non-U.S. Gov't
PubMed ID	18585523

Advertise on this site.